BCYC Q2 2024 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9M-17.9% YoY

Gross Profit

$9M100.0% margin

Operating Income

-$47M-498.3% margin

Net Income

-$40M-425.3% margin

EPS (Diluted)

$-0.77

QoQ Revenue Growth

-52.1%

Cash Flow

Operating Cash Flow

-$45M

Free Cash Flow

-$45M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$184M

Stockholders' Equity

$874M

Cash & Equivalents

$961M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$11M	-17.9%
Gross Profit	$9M	$11M	-17.9%
Operating Income	-$47M	-$43M	-8.2%
Net Income	-$40M	-$43M	+6.6%